The United States is entering an unusually early influenza season, with the cumulative hospitalization rate reaching 5.0 per 100,000 people by the week ending November 5—higher than the rate recorded at the same point in every season since CDC's current comparison period began in 2010–11. The latest FluView surveillance summary reports 1,472 laboratory-confirmed influenza-associated hospitalizations across the FluSurv-NET system since October 1, with influenza A accounting for more than 96% of those cases.

The timing is the central concern. A hospitalization rate of 5.0 per 100,000 would not by itself define the eventual severity of a full flu season, but it is striking for early November. In previous seasons since 2010–11, the cumulative rate at this point ranged from 0.1 to 0.7 per 100,000. Children younger than five and adults 65 and older are already experiencing some of the highest age-specific rates, placing pressure on pediatric and adult care systems before the traditional winter peak.

An early wave is translating into hospital admissions

CDC warned two weeks ago that influenza activity was rising earlier than usual. Its October 28 early-wave report counted 443 hospitalizations through October 22 in FluSurv-NET, already the highest number reported by that point of the season in a decade. National hospital reporting captured nearly 5,500 flu admissions from early October through the week ending October 22.

The newest surveillance data show that the increase has continued. Among FluSurv-NET hospitalizations with influenza A subtype information, roughly three-quarters were associated with A(H3N2), while about one-quarter were A(H1N1)pdm09. H3N2-dominant seasons can be difficult for older adults, though the final severity of the current season cannot be inferred from subtype alone.

Clinical laboratory positivity has also climbed rapidly as influenza spreads across more regions. CDC's surveillance combines multiple systems because no single measure captures the national epidemic. Outpatient respiratory illness, laboratory testing, hospitalization networks, mortality surveillance and state reporting each describe a different part of the picture. The hospitalization signal is particularly important because it measures serious disease rather than infection alone.

Children and older adults face the highest early risk

Through November 5, CDC reported a hospitalization rate of 10.7 per 100,000 among adults 65 and older and 9.3 per 100,000 among children younger than five. Those rates are substantially above the early-season ranges observed for the same age groups in recent years. The pattern reinforces long-standing guidance that influenza is not simply a short-lived respiratory inconvenience for everyone; it can lead to pneumonia, worsening chronic disease and hospitalization, particularly at the extremes of age.

The Advisory Committee on Immunization Practices' 2022–23 recommendations call for annual influenza vaccination for everyone six months and older who does not have a contraindication. For adults 65 and older, the committee this year preferentially recommends one of three higher-dose or adjuvanted vaccines when available, based on evidence that those formulations may produce better protection in an age group with weaker immune responses.

The vaccine composition was selected months before the season began. The Food and Drug Administration's March vaccine advisory meeting addressed strain selection for the 2022–23 Northern Hemisphere season. U.S. vaccines are quadrivalent and include H1N1, H3N2 and two influenza B lineage components. Matching circulating strains is one element of effectiveness, but vaccination can still reduce the risk of severe outcomes even when infections occur.

Public-health officials are pushing vaccination after October

The early start has made the calendar more urgent. CDC generally advises most people to receive a flu vaccine in September or October, but the recommendation explicitly continues after October as long as influenza viruses are circulating and vaccine remains available. That matters now because millions of people who have not yet been vaccinated still have an opportunity to develop protection while activity is increasing.

CDC, the American Medical Association and the Ad Council launched a national campaign in October emphasizing vaccination as a way to reduce illness, hospitalization and disruption to families during the holidays. A separate CDC season kickoff urged parents in particular to vaccinate young children and reiterated the recommendation for everyone six months and older.

Vaccination is not instantaneous. The immune response generally takes about two weeks to develop, so an early epidemic means people who wait until influenza is widespread in their own communities may have less time to establish protection. Clinicians also have antiviral medications available for treatment, with the greatest benefit generally expected when therapy begins early, particularly for people at higher risk of complications.

The burden could collide with other respiratory viruses

Hospitals are also treating substantial respiratory syncytial virus activity in children, while COVID-19 continues to circulate. That combination raises the possibility of simultaneous demand for emergency, inpatient and pediatric beds. Each virus has different epidemiology and prevention tools, but they compete for the same clinical capacity when severe cases rise together.

CDC's August vaccination guidance stresses that people at higher risk of influenza complications include young children, older adults, pregnant people and those with chronic pulmonary, cardiovascular, renal, hepatic, neurologic, hematologic or metabolic conditions. The unusually early hospitalization trajectory makes those recommendations more immediate than they might appear in a typical November.

It remains too early to know whether the 2022–23 flu season will ultimately be severe. Influenza activity can accelerate, plateau or change as different strains move through regions, and preliminary hospitalization data are revised as cases are reported. But the current comparison is already clear: serious influenza is arriving earlier than the country has become accustomed to seeing it. With the holiday travel season approaching, public-health officials are treating vaccination and prompt clinical attention for high-risk patients as the most practical tools available to reduce the next wave of hospitalizations.